White Spot Lesions [Initial Caries] on Smooth Surface of ToothNCT07845110
EFFICACY OF BIOMIN FLUORIDE VERSUS SODIUM FLUORIDE VARNISHES, WITH AND WITHOUT DIODE LASER ON WHITE SPOT LESIONS REMINERALIZATION IN PRIMARY TEETH.
A study testing BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser) and (Duraphat varnish + Diode laser) in people with White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, run by Yassmin Mohamed at 2 sites in Egypt.
Trial summary
The goal of this randomized controlled clinical trial is to assess and compare the remineralizing effect of Biomin fluoride varnish and conventional 5% sodium fluoride varnish (Duraphat), with and without adjunctive low-level diode laser irradiation, in preschool children with active white spot lesions in primary… Read more about this study
- Who is it for?
- Ages 3 to 6 years
- Conditions the study is for
- White Spot Lesions [Initial Caries] on Smooth Surface of Tooth
- What is being tested?
- BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser) and (Duraphat varnish + Diode laser)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 2 sitesEgypt
- Study dates
- 1 Oct 2026to 1 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 6 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- • Healthy Children aged 3-6 years old.
- Patients ranking definitely positive or positive on Frankel scale
- The Presence of at least one active non-cavitated white spot lesion (ICDAS code 1 or 2) on the facial surface of primary teeth .
- Completion of an informed consent by the guardian to participate in the study
Who cannot join
- History of systemic disease or medication affecting enamel development
- Teeth with cavitated lesions (ICDAS ≥ 3)
- Previous professional fluoride treatment or laser therapy in the last 3 months
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt2 sites, 2 recruiting
- Recruiting
Faculty of Dentistry, Alexandria university, Egypt
Alexandria, Alexandria Governorate, 21519
- Recruiting
Faculty of Dentistry, Alexandria university, Egypt
Alexandria, Alexandria Governorate, 21519
Yassmin Mohamed Hassan, BDs, +20 1005364640, yassmin.moh150@gmail.com
About this study
Official title: EFFICACY OF BIOMIN FLUORIDE VERSUS SODIUM FLUORIDE VARNISHES, WITH AND WITHOUT DIODE LASER ON WHITE SPOT LESIONS REMINERALIZATION IN PRIMARY TEETH (A RANDOMIZED CONTROLLED CLINICAL TRIAL)
The goal of this randomized controlled clinical trial is to assess and compare the remineralizing effect of Biomin fluoride varnish and conventional 5% sodium fluoride varnish (Duraphat), with and without adjunctive low-level diode laser irradiation, in preschool children with active white spot lesions in primary anterior teeth. The study will include healthy children aged 3-6 years with at least one active, non-cavitated white spot lesion (ICDAS-II score 1 or 2). The study will be conducted at the Faculty of Dentistry, Alexandria University, with a total of 80 lesions randomly allocated to four parallel groups.
The main questions it aims to answer are:
Read more
Does Biomin fluoride varnish produce a different remineralizing effect compared with conventional 5% sodium fluoride varnish (Duraphat) after 6 months? Does adding 980-nm low-level diode laser irradiation to Biomin fluoride varnish or Duraphat improve the remineralization of white spot lesions compared with the corresponding varnish alone? Do the different treatments result in changes in lesion severity and activity, as assessed by ICDAS-II and DIAGNOdent readings? Do the treatments reduce the surface area of white spot lesions after 6 months?
Researchers will compare four treatment groups to assess differences in remineralization:
Group I (n=20): Biomin fluoride varnish (5% sodium fluoride incorporating bioactive glass).
Group II (n=20): Biomin fluoride varnish combined with low-level diode laser. Group III (n=20): Duraphat 5% sodium fluoride varnish combined with low-level diode laser.
Group IV (n=20): Duraphat 5% sodium fluoride varnish alone (control group).
Participants will:
Undergo baseline assessment of their white spot lesions using ICDAS-II visual-tactile examination, DIAGNOdent laser fluorescence, and standardized photographic assessment.
Receive the randomly assigned fluoride varnish treatment, with diode laser irradiation applied to Groups II and III using a 980-nm diode laser.
Return for follow-up assessments at 1, 3, and 6 months. At 3 months, the assigned varnish and laser treatment will be reapplied according to the group.
Have lesion severity and activity assessed using ICDAS-II and changes in mineralization assessed through DIAGNOdent readings. At 6 months, standardized photographs will also be used to evaluate changes in lesion surface area.
Follow post-treatment instructions, including avoiding fluoride-containing products on the day of varnish application and avoiding eating and drinking for at least 4 hours.
The primary outcome is caries arrest/remineralization assessed through changes in lesion severity and activity using ICDAS-II and changes in mean DIAGNOdent readings at 1, 3, and 6 months. The secondary outcome is the change in white spot lesion surface area measured by standardized photographic assessment at 6 months.
Read the detailed description
White spot lesions (WSLs) are early manifestations of enamel caries characterized by subsurface mineral loss while the enamel surface remains clinically intact. In primary teeth, early lesions may progress rapidly, making non-invasive remineralization an important approach for preserving tooth structure and preventing progression to cavitation. Fluoride varnish is widely used for the management of early enamel lesions; however, conventional fluoride varnishes may have limited retention on the tooth surface and may primarily promote remineralization near the enamel surface.
Bioactive glass-containing materials have been developed as an alternative or adjunctive remineralization strategy. Biomin fluoride varnish incorporates bioactive glass capable of releasing calcium, phosphate, and fluoride ions in the oral environment. According to the protocol, the sustained release of these ions may promote formation of fluorapatite and potentially provide deeper and longer-lasting remineralization of early enamel lesions.
Low-level diode laser irradiation has also been proposed as an adjunct to topical fluoride treatment. The protocol describes laser irradiation as potentially increasing enamel resistance to acid attack and enhancing fluoride uptake. However, previous findings cited in the protocol are not consistent: some studies have suggested a synergistic effect between laser irradiation and remineralizing agents, whereas other studies have not demonstrated an additional benefit when laser treatment is combined with fluoride or Biomin products. The protocol therefore identifies a need for clinical evaluation of these approaches in primary teeth.
This study is designed as a four-arm, parallel, randomized controlled clinical trial. Participants meeting the study criteria will be randomly allocated to receive one of the study treatment approaches. The allocation will be computer-generated with an equal allocation ratio, and treatment assignment will be concealed until the intervention. The outcome assessor will remain blinded to treatment allocation.
The study will evaluate the clinical and quantitative changes occurring in active, non-cavitated white spot lesions during a 6-month follow-up period. Lesion status will be monitored using clinical assessment with the International Caries Detection and Assessment System (ICDAS-II) and quantitative assessment using laser-induced fluorescence with the DIAGNOdent™ pen. These assessments will allow changes in lesion severity, activity, and fluorescence readings to be followed over time. Standardized photographic records will additionally be used at the end of follow-up to evaluate changes in the proportional surface area of the lesions.
Before treatment, eligible lesions will undergo baseline assessment following cleaning and standardized examination procedures. The investigator will be trained and calibrated in the use of ICDAS-II and DIAGNOdent™. Lesion activity will be assessed clinically, while DIAGNOdent measurements will provide numerical readings related to enamel demineralization. Standardized photographs will be obtained under controlled conditions to permit subsequent comparison of lesion size.
The assigned varnish will be applied according to the manufacturer's instructions. For participants allocated to the laser groups, the diode laser will be applied following varnish application using the parameters specified in the study protocol. Participants will receive post-treatment instructions concerning fluoride-containing products and eating and drinking following varnish application. At the 3-month visit, the assigned treatment will be reapplied, followed by the same post-application instructions.
Follow-up examinations will take place at predetermined intervals during the 6-month study period. Clinical and DIAGNOdent assessments will be repeated during follow-up, while standardized photographic assessment will be performed at the final visit. All follow-up assessments will be conducted by the same calibrated examiner, who will remain unaware of the treatment allocation.
The study is intended to determine whether the incorporation of bioactive glass into a fluoride varnish and/or the addition of low-level diode laser irradiation is associated with greater improvement in early white spot lesions than conventional fluoride varnish alone. The findings are expected to provide clinical evidence regarding the use of these non-invasive approaches for the management of early carious lesions in primary teeth.
The protocol states that written informed consent will be obtained from the parent or guardian before participation. The study activities will be conducted in accordance with the ethical requirements of the Faculty of Dentistry, Alexandria University, and the Declaration of Helsinki. Participants and their guardians will also receive oral hygiene and dietary instructions as part of the study procedures. The protocol reports that no study-related hazards or side effects are anticipated.
- Being tested
- BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser), (Duraphat varnish + Diode laser), Duraphat varnish (5% sodium fluoride varnish)
- Keywords
- Remineralization Primary Anterior Teeth Fluoride Varnish BioMin Fluoride Diode Laser
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing).Other
will be applied according to the manufacturer's instructions as follows
- Excess plaque should be removed
- Teeth should be isolated and gently dried
- BioMin fluoride varnish will be applied using a disposable microbrush in thin layer and allowed to set
(BioMin® + Diode Laser)Other
- After application of BioMin® fluoride varnish as described above, the tooth surface will be irradiated using a diode laser Wavelength: 980 nm.
- Operating Mode: Continuous wave.
- Fiber tip:320 µm.
- Radiant Energy :15 J.
- Mode: Non-contact mode.
- Duration: 30 seconds.
- Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant.
(Duraphat varnish + Diode laser)Other
After application of DURAPHAT fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters(16):
- Wavelength: 980 nm.
- Operating Mode: Continuous wave.
- Fiber tip:320 µm.
- Mode: Non-contact mode.
- Duration: 30 seconds.
- Radiant Energy: 15 J.
- Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant.
Duraphat varnish (5% sodium fluoride varnish)Other
will be applied to all white spot lesions according to the manufacturers' instructions as follows:
- Excess plaque should be removed
- Teeth should be isolated and gently dried
- Duraphat can be applied using a brush in a thin layer on the affected areas and allowed to set.
| Study group | Role | What they receive |
|---|---|---|
| Test group 1 | Experimental | • Group I (Test Group I): BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing).
will be applied according to the manufacturer's instructions as follows
1. Excess plaque should be removed
2. Teeth should be isolated and gently dried
3. BioMin fluoride varnish will be applied using a disposable microbrush in thin layer and allowed to set Receives: Other: BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing). |
| Test group 2 | Experimental | (BioMin® + Diode Laser): After application of BioMin® fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters:
* Wavelength: 980 nm.
* Operating Mode: Continuous wave.
* Fiber tip:320 µm.
* Radiant Energy :15 J.
* Mode: Non-contact mode.
* Duration: 30 seconds.
* Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant. Receives: Other: (BioMin® + Diode Laser) |
| Test group 3 | Experimental | (Duraphat varnish + Diode laser ): After application of DURAPHAT fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters:
* Wavelength: 980 nm.
* Operating Mode: Continuous wave.
* Fiber tip:320 µm.
* Mode: Non-contact mode.
* Duration: 30 seconds.
* Radiant Energy: 15 J.
* Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant. Receives: Other: (Duraphat varnish + Diode laser) |
| Control group | Active comparator | Duraphat varnish (5% sodium fluoride varnish) will be applied to all white spot lesions according to the manufacturers' instructions as follows:
1. Excess plaque should be removed
2. Teeth should be isolated and gently dried
3. Duraphat can be applied using a brush in a thin layer on the affected areas and allowed to set. Receives: Other: Duraphat varnish (5% sodium fluoride varnish) |
What is being measured
The primary outcome is the main question the study is designed to answer.
The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up .
The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up .
Measured: 6 months
Secondary outcomes (1)
• Assessment of the change in lesion surface area using standardized photographic assessment at 6 months follow up.
- Assessment of the change in lesion surface area using standardized photographic assessment at 6 months follow up.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2026
- Study start1 Oct 2026 (estimated)
- Primary completion1 Apr 2027 (estimated)
- Study completion1 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for White Spot Lesions [Initial Caries] on Smooth Surface of ToothStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Yassmin Mohamed
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Yassmin Mohamed, Alexandria University
- Investigators
- Dalia Mamdouh Talaat, professor, Study director, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07845110
- Sponsor's protocol ID
- 1227-01L2026
- Status last verified
- Sep 2026
- First submitted
- 22 Sep 2026
- Last updated
- 30 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- EFFICACY OF BIOMIN FLUORIDE VERSUS SODIUM FLUORIDE VARNISHES, WITH AND WITHOUT DIODE LASER ON WHITE SPOT LESIONS REMINERALIZATION IN PRIMARY TEETH (A RANDOMIZED CONTROLLED CLINICAL TRIAL)
- ClinicalTrials.gov ID
- NCT07845110
- Acronym / sponsor ID
- 1227-01L2026
- Keywords
- Remineralization Primary Anterior Teeth Fluoride Varnish BioMin Fluoride Diode Laser
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Yassmin MohamedUniversity, hospital or other
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 1 Apr 2027 (estimated)
- Study completion
- 1 Apr 2027 (estimated)
- First posted
- 28 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this randomized controlled clinical trial is to assess and compare the remineralizing effect of Biomin fluoride varnish and conventional 5% sodium fluoride varnish (Duraphat), with and without adjunctive low-level diode laser irradiation, in preschool children with active white spot lesions in primary anterior teeth. The study will include healthy children aged 3-6 years with at least one active, non-cavitated white spot lesion (ICDAS-II score 1 or 2). The study will be conducted at the Faculty of Dentistry, Alexandria University, with a total of 80 lesions randomly allocated to four parallel groups.
The main questions it aims to answer are:
Does Biomin fluoride varnish produce a different remineralizing effect compared with conventional 5% sodium fluoride varnish (Duraphat) after 6 months? Does adding 980-nm low-level diode laser irradiation to Biomin fluoride varnish or Duraphat improve the remineralization of white spot lesions compared with the corresponding varnish alone? Do the different treatments result in changes in lesion severity and activity, as assessed by ICDAS-II and DIAGNOdent readings? Do the treatments reduce the surface area of white spot lesions after 6 months?
Researchers will compare four treatment groups to assess differences in remineralization:
Group I (n=20): Biomin fluoride varnish (5% sodium fluoride incorporating bioactive glass).
Group II (n=20): Biomin fluoride varnish combined with low-level diode laser. Group III (n=20): Duraphat 5% sodium fluoride varnish combined with low-level diode laser.
Group IV (n=20): Duraphat 5% sodium fluoride varnish alone (control group).
Participants will:
Undergo baseline assessment of their white spot lesions using ICDAS-II visual-tactile examination, DIAGNOdent laser fluorescence, and standardized photographic assessment.
Receive the randomly assigned fluoride varnish treatment, with diode laser irradiation applied to Groups II and III using a 980-nm diode laser.
Return for follow-up assessments at 1, 3, and 6 months. At 3 months, the assigned varnish and laser treatment will be reapplied according to the group.
Have lesion severity and activity assessed using ICDAS-II and changes in mineralization assessed through DIAGNOdent readings. At 6 months, standardized photographs will also be used to evaluate changes in lesion surface area.
Follow post-treatment instructions, including avoiding fluoride-containing products on the day of varnish application and avoiding eating and drinking for at least 4 hours.
The primary outcome is caries arrest/remineralization assessed through changes in lesion severity and activity using ICDAS-II and changes in mean DIAGNOdent readings at 1, 3, and 6 months. The secondary outcome is the change in white spot lesion surface area measured by standardized photographic assessment at 6 months.
Detailed description
White spot lesions (WSLs) are early manifestations of enamel caries characterized by subsurface mineral loss while the enamel surface remains clinically intact. In primary teeth, early lesions may progress rapidly, making non-invasive remineralization an important approach for preserving tooth structure and preventing progression to cavitation. Fluoride varnish is widely used for the management of early enamel lesions; however, conventional fluoride varnishes may have limited retention on the tooth surface and may primarily promote remineralization near the enamel surface.
Bioactive glass-containing materials have been developed as an alternative or adjunctive remineralization strategy. Biomin fluoride varnish incorporates bioactive glass capable of releasing calcium, phosphate, and fluoride ions in the oral environment. According to the protocol, the sustained release of these ions may promote formation of fluorapatite and potentially provide deeper and longer-lasting remineralization of early enamel lesions.
Low-level diode laser irradiation has also been proposed as an adjunct to topical fluoride treatment. The protocol describes laser irradiation as potentially increasing enamel resistance to acid attack and enhancing fluoride uptake. However, previous findings cited in the protocol are not consistent: some studies have suggested a synergistic effect between laser irradiation and remineralizing agents, whereas other studies have not demonstrated an additional benefit when laser treatment is combined with fluoride or Biomin products. The protocol therefore identifies a need for clinical evaluation of these approaches in primary teeth.
This study is designed as a four-arm, parallel, randomized controlled clinical trial. Participants meeting the study criteria will be randomly allocated to receive one of the study treatment approaches. The allocation will be computer-generated with an equal allocation ratio, and treatment assignment will be concealed until the intervention. The outcome assessor will remain blinded to treatment allocation.
The study will evaluate the clinical and quantitative changes occurring in active, non-cavitated white spot lesions during a 6-month follow-up period. Lesion status will be monitored using clinical assessment with the International Caries Detection and Assessment System (ICDAS-II) and quantitative assessment using laser-induced fluorescence with the DIAGNOdent™ pen. These assessments will allow changes in lesion severity, activity, and fluorescence readings to be followed over time. Standardized photographic records will additionally be used at the end of follow-up to evaluate changes in the proportional surface area of the lesions.
Before treatment, eligible lesions will undergo baseline assessment following cleaning and standardized examination procedures. The investigator will be trained and calibrated in the use of ICDAS-II and DIAGNOdent™. Lesion activity will be assessed clinically, while DIAGNOdent measurements will provide numerical readings related to enamel demineralization. Standardized photographs will be obtained under controlled conditions to permit subsequent comparison of lesion size.
The assigned varnish will be applied according to the manufacturer's instructions. For participants allocated to the laser groups, the diode laser will be applied following varnish application using the parameters specified in the study protocol. Participants will receive post-treatment instructions concerning fluoride-containing products and eating and drinking following varnish application. At the 3-month visit, the assigned treatment will be reapplied, followed by the same post-application instructions.
Follow-up examinations will take place at predetermined intervals during the 6-month study period. Clinical and DIAGNOdent assessments will be repeated during follow-up, while standardized photographic assessment will be performed at the final visit. All follow-up assessments will be conducted by the same calibrated examiner, who will remain unaware of the treatment allocation.
The study is intended to determine whether the incorporation of bioactive glass into a fluoride varnish and/or the addition of low-level diode laser irradiation is associated with greater improvement in early white spot lesions than conventional fluoride varnish alone. The findings are expected to provide clinical evidence regarding the use of these non-invasive approaches for the management of early carious lesions in primary teeth.
The protocol states that written informed consent will be obtained from the parent or guardian before participation. The study activities will be conducted in accordance with the ethical requirements of the Faculty of Dentistry, Alexandria University, and the Declaration of Helsinki. Participants and their guardians will also receive oral hygiene and dietary instructions as part of the study procedures. The protocol reports that no study-related hazards or side effects are anticipated.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Test group 1 | Experimental | Other: BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing).• Group I (Test Group I): BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing). will be applied according to the manufacturer's instructions as follows 1. Excess plaque should be removed 2. Teeth should be isolated and gently dried 3. BioMin fluoride varnish will be applied using a disposable microbrush in thin layer and allowed to set |
| Test group 2 | Experimental | Other: (BioMin® + Diode Laser)(BioMin® + Diode Laser): After application of BioMin® fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters: * Wavelength: 980 nm. * Operating Mode: Continuous wave. * Fiber tip:320 µm. * Radiant Energy :15 J. * Mode: Non-contact mode. * Duration: 30 seconds. * Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant. |
| Test group 3 | Experimental | Other: (Duraphat varnish + Diode laser)(Duraphat varnish + Diode laser ): After application of DURAPHAT fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters: * Wavelength: 980 nm. * Operating Mode: Continuous wave. * Fiber tip:320 µm. * Mode: Non-contact mode. * Duration: 30 seconds. * Radiant Energy: 15 J. * Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant. |
| Control group | Active comparator | Other: Duraphat varnish (5% sodium fluoride varnish)Duraphat varnish (5% sodium fluoride varnish) will be applied to all white spot lesions according to the manufacturers' instructions as follows: 1. Excess plaque should be removed 2. Teeth should be isolated and gently dried 3. Duraphat can be applied using a brush in a thin layer on the affected areas and allowed to set. |
Who may qualify
- Ages
- 3 to 6 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- • Healthy Children aged 3-6 years old.
Key exclusion criteria (3 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing).will be applied according to the manufacturer's instructions as follows 1. Excess plaque should be removed 2. Teeth should be isolated and gently dried 3. BioMin fluoride varnish will be applied using a disposable microbrush in thin layer and allowed to set | Other | Test group 1 |
| (BioMin® + Diode Laser)* After application of BioMin® fluoride varnish as described above, the tooth surface will be irradiated using a diode laser Wavelength: 980 nm. * Operating Mode: Continuous wave. * Fiber tip:320 µm. * Radiant Energy :15 J. * Mode: Non-contact mode. * Duration: 30 seconds. * Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant. | Other | Test group 2 |
| (Duraphat varnish + Diode laser)After application of DURAPHAT fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters(16): * Wavelength: 980 nm. * Operating Mode: Continuous wave. * Fiber tip:320 µm. * Mode: Non-contact mode. * Duration: 30 seconds. * Radiant Energy: 15 J. * Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant. | Other | Test group 3 |
| Duraphat varnish (5% sodium fluoride varnish)will be applied to all white spot lesions according to the manufacturers' instructions as follows: 1. Excess plaque should be removed 2. Teeth should be isolated and gently dried 3. Duraphat can be applied using a brush in a thin layer on the affected areas and allowed to set. | Other | Control group |
Primary outcome
The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up .
Time frame: 6 months
The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up .
1 secondary outcome
• Assessment of the change in lesion surface area using standardized photographic assessment at 6 months follow up.
Time frame: 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Dalia Mamdouh Talaat, professor study director
Alexandria University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser) and (Duraphat varnish + Diode laser) in people with White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, run by Yassmin Mohamed at 2 sites in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yassmin Mohamed Hassan, BDs (+20 01005364640, yassmin.moh150@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up . (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.